Highlights
ASX: TLX       TELIX PHARMACEUTICALS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
1.01   +0.01 (1.00%)  0.995 - 1.03  223,091

Overview

 
Avg Volume (4 weeks):363,536
4 Weeks Range:0.85 - 1.145
4 Weeks Price Volatility (%):
54.24%
52 Weeks Range:0.54 - 1.145
52 Weeks Price Volatility (%):
77.69%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on development and commercialization of diagnostic and therapeutic products based on radiopharmaceuticals, or molecularly-targeted radiation (MTR). MTR is a novel therapeutic approach that selectively delivers radiation to cells that exhibit certain molecular profiles or targets that may be indicative of cancer. The Company's MTR products such as TLX-250 diagnosis and treatment of renal (kidney), TLX-591 treatment of metastatic castrate-resistant prostate cancer, and TLX-101 treatment of glioblastoma (brain cancer).

  Be the first to like this.
 


 

584  642  694  9247 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CLZ 0.0010.00 
 ROG 0.0020.00 
 CLA 0.051-0.015 
 TLS 3.81+0.01 
 RED 0.155-0.005 
 OEL 0.044-0.003 
 ADN 0.011-0.001 
 AJC 0.0010.00 
 S32 3.170.00 
 CLI 0.046-0.009 
Partners & Brokers